Post-Mastectomy Radiotherapy in pT1–2N1 HER2-Enriched Breast Cancer: Reassessing Its Role in the Anti-HER2 Era
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S246
DOI: 10.1016/j.ijrobp.2026.06.526 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von X. Wang und 13 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wang, X., Zhang, L., Guo, J., Zhang, X., Meng, J., Shi, W., Chen, X., Yang, Z., Mei, X., Zhang, Z., Shao, Z., Guo, X., Yu, X., & Ma, J. (2026). Post-Mastectomy Radiotherapy in pT1–2N1 HER2-Enriched Breast Cancer: Reassessing Its Role in the Anti-HER2 Era. International Journal of Radiation Oncology*Biology*Physics, 126(1), S246. https://doi.org/10.1016/j.ijrobp.2026.06.526
Vancouver
Wang X, Zhang L, Guo J, Zhang X, Meng J, Shi W, et al. Post-Mastectomy Radiotherapy in pT1–2N1 HER2-Enriched Breast Cancer: Reassessing Its Role in the Anti-HER2 Era. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S246. doi:10.1016/j.ijrobp.2026.06.526
BibTeX
@article{Wang2026,
author = {Wang, X. and Zhang, L. and Guo, J. and Zhang, X. and Meng, J. and Shi, W. and Chen, X. and Yang, Z. and Mei, X. and Zhang, Z. and Shao, Z. and Guo, X.M. and Yu, X. and Ma, J.},
title = {Post-Mastectomy Radiotherapy in pT1–2N1 HER2-Enriched Breast Cancer: Reassessing Its Role in the Anti-HER2 Era},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {S246},
doi = {10.1016/j.ijrobp.2026.06.526}
}
EUVIMED